QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Appoints Ori Gon as CFO and Chief Business Officer
Regentis Biomaterials (NYSE American: RGNT) announced the appointment of Ori Gon as chief financial officer and chief business officer, effective immediately. Gon will oversee the company’s commercial and business development initiatives, as well as financial strategy, planning and reporting, as Regentis advances GelrinC(R) toward commercialization in Europe following CE Mark approval and continues its pivotal Phase III FDA clinical trial in the United States. To view the full press release, visit https://ibn.fm/E8WA4 About Regentis Biomaterials Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an…